nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP2D6—Parkinson's disease	0.744	1	CbGaD
Diphenhydramine—Alverine—HTR1A—Parkinson's disease	0.00092	0.0542	CrCbGaD
Diphenhydramine—Captodiame—DRD3—Parkinson's disease	0.000892	0.0526	CrCbGaD
Diphenhydramine—Benzphetamine—SLC18A2—Parkinson's disease	0.000764	0.045	CrCbGaD
Diphenhydramine—Diphenylpyraline—SLC6A3—Parkinson's disease	0.000644	0.0379	CrCbGaD
Diphenhydramine—Benzatropine—SLC6A3—Parkinson's disease	0.000494	0.0291	CrCbGaD
Diphenhydramine—Reboxetine—CYP2D6—Parkinson's disease	0.00041	0.0242	CrCbGaD
Diphenhydramine—Bifonazole—CYP2E1—Parkinson's disease	0.000398	0.0235	CrCbGaD
Diphenhydramine—Clomifene—CYP2E1—Parkinson's disease	0.000383	0.0226	CrCbGaD
Diphenhydramine—Chlorphenamine—SLC6A3—Parkinson's disease	0.000374	0.0221	CrCbGaD
Diphenhydramine—Modafinil—SLC6A3—Parkinson's disease	0.000365	0.0215	CrCbGaD
Diphenhydramine—Tripelennamine—CYP2D6—Parkinson's disease	0.000338	0.0199	CrCbGaD
Diphenhydramine—Benzphetamine—SLC6A3—Parkinson's disease	0.000317	0.0187	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP2E1—Parkinson's disease	0.000315	0.0186	CrCbGaD
Diphenhydramine—Atomoxetine—SLC6A3—Parkinson's disease	0.000314	0.0185	CrCbGaD
Diphenhydramine—Cyclobenzaprine—HTR2A—Parkinson's disease	0.000307	0.0181	CrCbGaD
Diphenhydramine—Reboxetine—ABCB1—Parkinson's disease	0.000293	0.0173	CrCbGaD
Diphenhydramine—Cyclobenzaprine—CYP2D6—Parkinson's disease	0.000281	0.0166	CrCbGaD
Diphenhydramine—Brompheniramine—CYP2E1—Parkinson's disease	0.000273	0.0161	CrCbGaD
Diphenhydramine—Cinnarizine—DRD2—Parkinson's disease	0.000263	0.0155	CrCbGaD
Diphenhydramine—Benzatropine—CYP2D6—Parkinson's disease	0.000259	0.0153	CrCbGaD
Diphenhydramine—Trimipramine—SLC6A3—Parkinson's disease	0.000259	0.0152	CrCbGaD
Diphenhydramine—Toremifene—ABCB1—Parkinson's disease	0.000232	0.0137	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP2D6—Parkinson's disease	0.000231	0.0136	CrCbGaD
Diphenhydramine—Promazine—DRD1—Parkinson's disease	0.000231	0.0136	CrCbGaD
Diphenhydramine—Trimipramine—HTR1A—Parkinson's disease	0.000227	0.0134	CrCbGaD
Diphenhydramine—Imipramine—HTR7—Parkinson's disease	0.000219	0.0129	CrCbGaD
Diphenhydramine—Amitriptyline—HTR7—Parkinson's disease	0.000218	0.0128	CrCbGaD
Diphenhydramine—Doxepin—HTR1A—Parkinson's disease	0.000216	0.0127	CrCbGaD
Diphenhydramine—Amitriptyline—DRD3—Parkinson's disease	0.000205	0.0121	CrCbGaD
Diphenhydramine—Bepridil—CYP2D6—Parkinson's disease	0.000204	0.012	CrCbGaD
Diphenhydramine—Clomifene—ABCB1—Parkinson's disease	0.000201	0.0118	CrCbGaD
Diphenhydramine—Brompheniramine—CYP2D6—Parkinson's disease	0.0002	0.0118	CrCbGaD
Diphenhydramine—Chlorphenamine—CYP2D6—Parkinson's disease	0.000197	0.0116	CrCbGaD
Diphenhydramine—Trimipramine—DRD2—Parkinson's disease	0.000192	0.0113	CrCbGaD
Diphenhydramine—Imipramine—SLC6A3—Parkinson's disease	0.000192	0.0113	CrCbGaD
Diphenhydramine—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.00019	0.0112	CrCbGaD
Diphenhydramine—Cinnarizine—CYP2D6—Parkinson's disease	0.000186	0.011	CrCbGaD
Diphenhydramine—Promethazine—DRD2—Parkinson's disease	0.000185	0.0109	CrCbGaD
Diphenhydramine—Doxepin—DRD2—Parkinson's disease	0.000183	0.0108	CrCbGaD
Diphenhydramine—Atomoxetine—HTR2A—Parkinson's disease	0.000181	0.0106	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2E1—Parkinson's disease	0.000177	0.0104	CrCbGaD
Diphenhydramine—Orphenadrine—CYP2E1—Parkinson's disease	0.000172	0.0101	CrCbGaD
Diphenhydramine—Imipramine—HTR1A—Parkinson's disease	0.000168	0.0099	CrCbGaD
Diphenhydramine—Amitriptyline—HTR1A—Parkinson's disease	0.000167	0.00984	CrCbGaD
Diphenhydramine—Atomoxetine—CYP2D6—Parkinson's disease	0.000165	0.00974	CrCbGaD
Diphenhydramine—Promazine—DRD2—Parkinson's disease	0.000163	0.0096	CrCbGaD
Diphenhydramine—Trimipramine—HTR2A—Parkinson's disease	0.000149	0.00876	CrCbGaD
Diphenhydramine—Bepridil—ABCB1—Parkinson's disease	0.000146	0.0086	CrCbGaD
Diphenhydramine—Promethazine—HTR2A—Parkinson's disease	0.000143	0.00843	CrCbGaD
Diphenhydramine—Imipramine—DRD2—Parkinson's disease	0.000143	0.00841	CrCbGaD
Diphenhydramine—Amitriptyline—DRD2—Parkinson's disease	0.000142	0.00835	CrCbGaD
Diphenhydramine—Doxepin—HTR2A—Parkinson's disease	0.000142	0.00835	CrCbGaD
Diphenhydramine—Imipramine—CYP2E1—Parkinson's disease	0.000137	0.00809	CrCbGaD
Diphenhydramine—Amitriptyline—CYP2E1—Parkinson's disease	0.000136	0.00804	CrCbGaD
Diphenhydramine—Trimipramine—CYP2D6—Parkinson's disease	0.000136	0.00801	CrCbGaD
Diphenhydramine—Fentanyl—ABCB1—Parkinson's disease	0.000134	0.00791	CrCbGaD
Diphenhydramine—Promethazine—CYP2D6—Parkinson's disease	0.000131	0.00771	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2D6—Parkinson's disease	0.00013	0.00766	CrCbGaD
Diphenhydramine—Doxepin—CYP2D6—Parkinson's disease	0.000129	0.00763	CrCbGaD
Diphenhydramine—Methadone—CYP2D6—Parkinson's disease	0.000129	0.00759	CrCbGaD
Diphenhydramine—Promazine—HTR2A—Parkinson's disease	0.000126	0.00742	CrCbGaD
Diphenhydramine—Phenytoin—ABCB1—Parkinson's disease	0.000122	0.00717	CrCbGaD
Diphenhydramine—Imipramine—HTR2A—Parkinson's disease	0.00011	0.0065	CrCbGaD
Diphenhydramine—Amitriptyline—HTR2A—Parkinson's disease	0.00011	0.00646	CrCbGaD
Diphenhydramine—Imipramine—CYP2D6—Parkinson's disease	0.000101	0.00594	CrCbGaD
Diphenhydramine—Amitriptyline—CYP2D6—Parkinson's disease	0.0001	0.0059	CrCbGaD
Diphenhydramine—Trimipramine—ABCB1—Parkinson's disease	9.7e-05	0.00572	CrCbGaD
Diphenhydramine—Promethazine—ABCB1—Parkinson's disease	9.34e-05	0.00551	CrCbGaD
Diphenhydramine—Tamoxifen—ABCB1—Parkinson's disease	9.28e-05	0.00547	CrCbGaD
Diphenhydramine—Doxepin—ABCB1—Parkinson's disease	9.25e-05	0.00545	CrCbGaD
Diphenhydramine—Methadone—ABCB1—Parkinson's disease	9.2e-05	0.00542	CrCbGaD
Diphenhydramine—Imipramine—ABCB1—Parkinson's disease	7.2e-05	0.00424	CrCbGaD
Diphenhydramine—Amitriptyline—ABCB1—Parkinson's disease	7.15e-05	0.00422	CrCbGaD
Diphenhydramine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	5.58e-05	0.000233	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	5.58e-05	0.000233	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—OMD—Parkinson's disease	5.55e-05	0.000232	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	5.55e-05	0.000232	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	5.55e-05	0.000232	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	5.55e-05	0.000232	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	5.51e-05	0.00023	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	5.49e-05	0.000229	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	5.49e-05	0.000229	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.41e-05	0.000226	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—COMT—Parkinson's disease	5.38e-05	0.000225	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GSTP1—Parkinson's disease	5.36e-05	0.000224	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—MAOA—Parkinson's disease	5.34e-05	0.000223	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.3e-05	0.000222	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.28e-05	0.000221	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—DBH—Parkinson's disease	5.28e-05	0.000221	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GBA—Parkinson's disease	5.28e-05	0.000221	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—HMOX1—Parkinson's disease	5.28e-05	0.000221	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTA4—Parkinson's disease	5.27e-05	0.00022	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	5.26e-05	0.00022	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—FBP1—Parkinson's disease	5.24e-05	0.000219	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GBA—Parkinson's disease	5.24e-05	0.000219	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—DBH—Parkinson's disease	5.24e-05	0.000219	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	5.23e-05	0.000219	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	5.16e-05	0.000216	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	5.14e-05	0.000215	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	5.07e-05	0.000212	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—ABCB1—Parkinson's disease	5.07e-05	0.000212	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	5.06e-05	0.000212	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	5.06e-05	0.000212	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GCH1—Parkinson's disease	5.02e-05	0.00021	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	4.98e-05	0.000208	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	4.98e-05	0.000208	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GSTM1—Parkinson's disease	4.92e-05	0.000206	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	4.85e-05	0.000203	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	4.79e-05	0.0002	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	4.77e-05	0.000199	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	4.74e-05	0.000198	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	4.72e-05	0.000197	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP2D6—Parkinson's disease	4.71e-05	0.000197	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GPX1—Parkinson's disease	4.71e-05	0.000197	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MAOB—Parkinson's disease	4.7e-05	0.000196	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CTGF—Parkinson's disease	4.63e-05	0.000193	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP2D6—Parkinson's disease	4.58e-05	0.000191	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.53e-05	0.000189	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CTGF—Parkinson's disease	4.49e-05	0.000188	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—DBH—Parkinson's disease	4.48e-05	0.000187	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GBA—Parkinson's disease	4.48e-05	0.000187	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—FBP1—Parkinson's disease	4.48e-05	0.000187	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	4.46e-05	0.000187	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP2D6—Parkinson's disease	4.39e-05	0.000184	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	4.39e-05	0.000184	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—MTHFR—Parkinson's disease	4.35e-05	0.000182	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CTGF—Parkinson's disease	4.31e-05	0.00018	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP2E1—Parkinson's disease	4.31e-05	0.00018	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—NQO1—Parkinson's disease	4.26e-05	0.000178	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.25e-05	0.000178	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—DDC—Parkinson's disease	4.22e-05	0.000176	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	4.2e-05	0.000176	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—TH—Parkinson's disease	4.2e-05	0.000176	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP2E1—Parkinson's disease	4.18e-05	0.000175	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—NQO1—Parkinson's disease	4.14e-05	0.000173	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	4.14e-05	0.000173	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—TH—Parkinson's disease	4.08e-05	0.000171	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	4.08e-05	0.00017	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	4.05e-05	0.000169	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—APOE—Parkinson's disease	4.05e-05	0.000169	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYCS—Parkinson's disease	4.03e-05	0.000169	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP2E1—Parkinson's disease	4.02e-05	0.000168	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	4.01e-05	0.000168	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	3.99e-05	0.000167	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	3.98e-05	0.000167	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—NQO1—Parkinson's disease	3.97e-05	0.000166	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.93e-05	0.000164	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—TH—Parkinson's disease	3.92e-05	0.000164	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYCS—Parkinson's disease	3.92e-05	0.000164	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.91e-05	0.000163	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—DDC—Parkinson's disease	3.88e-05	0.000162	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—DDC—Parkinson's disease	3.85e-05	0.000161	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	3.84e-05	0.000161	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—INSR—Parkinson's disease	3.76e-05	0.000157	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYCS—Parkinson's disease	3.76e-05	0.000157	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	3.7e-05	0.000155	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.66e-05	0.000153	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	3.63e-05	0.000152	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	3.59e-05	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.59e-05	0.00015	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—COMT—Parkinson's disease	3.57e-05	0.000149	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GSTP1—Parkinson's disease	3.56e-05	0.000149	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGB—Parkinson's disease	3.55e-05	0.000149	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MAOB—Parkinson's disease	3.55e-05	0.000148	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MAOA—Parkinson's disease	3.55e-05	0.000148	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	3.55e-05	0.000148	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	3.54e-05	0.000148	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—HMOX1—Parkinson's disease	3.51e-05	0.000147	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	3.5e-05	0.000146	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	3.49e-05	0.000146	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	3.49e-05	0.000146	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	3.48e-05	0.000146	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	3.48e-05	0.000145	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—COMT—Parkinson's disease	3.47e-05	0.000145	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—INS—Parkinson's disease	3.46e-05	0.000145	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GSTP1—Parkinson's disease	3.45e-05	0.000144	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MAOA—Parkinson's disease	3.44e-05	0.000144	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CTGF—Parkinson's disease	3.43e-05	0.000143	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	3.43e-05	0.000143	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	3.41e-05	0.000143	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—HMOX1—Parkinson's disease	3.4e-05	0.000142	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.38e-05	0.000141	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ABCB1—Parkinson's disease	3.37e-05	0.000141	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	3.36e-05	0.000141	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—COMT—Parkinson's disease	3.33e-05	0.000139	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSTP1—Parkinson's disease	3.31e-05	0.000139	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	3.31e-05	0.000138	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MAOA—Parkinson's disease	3.31e-05	0.000138	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.3e-05	0.000138	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—DDC—Parkinson's disease	3.29e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.27e-05	0.000137	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—HMOX1—Parkinson's disease	3.27e-05	0.000137	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ABCB1—Parkinson's disease	3.27e-05	0.000137	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GSTM1—Parkinson's disease	3.27e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.26e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	3.25e-05	0.000136	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.24e-05	0.000135	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	3.19e-05	0.000134	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GSTM1—Parkinson's disease	3.17e-05	0.000133	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NQO1—Parkinson's disease	3.16e-05	0.000132	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ABCB1—Parkinson's disease	3.14e-05	0.000131	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GPX1—Parkinson's disease	3.13e-05	0.000131	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—TH—Parkinson's disease	3.11e-05	0.00013	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	3.1e-05	0.00013	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	3.09e-05	0.000129	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.08e-05	0.000129	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.06e-05	0.000128	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSTM1—Parkinson's disease	3.04e-05	0.000127	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	3.04e-05	0.000127	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GPX1—Parkinson's disease	3.04e-05	0.000127	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	2.99e-05	0.000125	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	2.99e-05	0.000125	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYCS—Parkinson's disease	2.99e-05	0.000125	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	2.94e-05	0.000123	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	2.94e-05	0.000123	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GPX1—Parkinson's disease	2.92e-05	0.000122	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MTHFR—Parkinson's disease	2.89e-05	0.000121	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MTHFR—Parkinson's disease	2.8e-05	0.000117	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.79e-05	0.000117	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.77e-05	0.000116	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MTHFR—Parkinson's disease	2.69e-05	0.000113	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—APOE—Parkinson's disease	2.69e-05	0.000112	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—COMT—Parkinson's disease	2.65e-05	0.000111	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	2.64e-05	0.00011	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTP1—Parkinson's disease	2.63e-05	0.00011	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.63e-05	0.00011	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MAOA—Parkinson's disease	2.63e-05	0.00011	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—APOE—Parkinson's disease	2.61e-05	0.000109	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—HMOX1—Parkinson's disease	2.6e-05	0.000109	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.59e-05	0.000108	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	2.51e-05	0.000105	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—APOE—Parkinson's disease	2.51e-05	0.000105	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ABCB1—Parkinson's disease	2.49e-05	0.000104	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	2.47e-05	0.000103	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	2.42e-05	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTM1—Parkinson's disease	2.42e-05	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.41e-05	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.41e-05	0.000101	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	2.39e-05	0.0001	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.39e-05	9.98e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	2.38e-05	9.97e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.38e-05	9.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.36e-05	9.87e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	2.36e-05	9.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TH—Parkinson's disease	2.35e-05	9.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GPX1—Parkinson's disease	2.32e-05	9.69e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—INS—Parkinson's disease	2.3e-05	9.6e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.26e-05	9.44e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—INS—Parkinson's disease	2.23e-05	9.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.22e-05	9.28e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NGF—Parkinson's disease	2.2e-05	9.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.2e-05	9.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.19e-05	9.18e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.18e-05	9.1e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	2.17e-05	9.05e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TH—Parkinson's disease	2.16e-05	9.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TH—Parkinson's disease	2.14e-05	8.96e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—INS—Parkinson's disease	2.14e-05	8.95e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTHFR—Parkinson's disease	2.14e-05	8.94e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	2.09e-05	8.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.08e-05	8.68e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	2.06e-05	8.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.06e-05	8.61e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	2.06e-05	8.59e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CTGF—Parkinson's disease	2.02e-05	8.44e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—COMT—Parkinson's disease	2e-05	8.36e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOE—Parkinson's disease	1.99e-05	8.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.99e-05	8.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.99e-05	8.3e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.96e-05	8.21e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOE—Parkinson's disease	1.95e-05	8.14e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	1.92e-05	8.01e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.88e-05	7.88e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.88e-05	7.86e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.86e-05	7.77e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.84e-05	7.69e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TH—Parkinson's disease	1.83e-05	7.66e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.83e-05	7.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.83e-05	7.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.83e-05	7.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—COMT—Parkinson's disease	1.82e-05	7.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.81e-05	7.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.81e-05	7.57e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.8e-05	7.55e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.79e-05	7.48e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.76e-05	7.35e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.75e-05	7.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.73e-05	7.24e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.72e-05	7.18e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—INS—Parkinson's disease	1.7e-05	7.11e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.68e-05	7.03e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.67e-05	6.97e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—INS—Parkinson's disease	1.66e-05	6.96e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—INS—Parkinson's disease	1.64e-05	6.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.62e-05	6.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.61e-05	6.73e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.6e-05	6.68e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—COMT—Parkinson's disease	1.56e-05	6.51e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.55e-05	6.48e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.55e-05	6.47e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.53e-05	6.39e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOE—Parkinson's disease	1.5e-05	6.29e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.49e-05	6.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.47e-05	6.16e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.47e-05	6.14e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.42e-05	5.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.38e-05	5.79e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOE—Parkinson's disease	1.37e-05	5.74e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.36e-05	5.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—INS—Parkinson's disease	1.29e-05	5.37e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.26e-05	5.26e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	1.24e-05	5.18e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	1.23e-05	5.15e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.22e-05	5.1e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.21e-05	5.06e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—INS—Parkinson's disease	1.18e-05	4.94e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOE—Parkinson's disease	1.17e-05	4.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—INS—Parkinson's disease	1.17e-05	4.9e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	1.14e-05	4.76e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.12e-05	4.68e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—INS—Parkinson's disease	1e-05	4.19e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—Parkinson's disease	7.27e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	7.15e-06	2.99e-05	CbGpPWpGaD
